WO2022156335A1 - Prothèse valvulaire cardiaque interventionnelle et appareil médical - Google Patents

Prothèse valvulaire cardiaque interventionnelle et appareil médical Download PDF

Info

Publication number
WO2022156335A1
WO2022156335A1 PCT/CN2021/131387 CN2021131387W WO2022156335A1 WO 2022156335 A1 WO2022156335 A1 WO 2022156335A1 CN 2021131387 W CN2021131387 W CN 2021131387W WO 2022156335 A1 WO2022156335 A1 WO 2022156335A1
Authority
WO
WIPO (PCT)
Prior art keywords
section
heart valve
valve
support
interventional
Prior art date
Application number
PCT/CN2021/131387
Other languages
English (en)
Chinese (zh)
Inventor
虞奇峰
秦涛
Original Assignee
上海纽脉医疗科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202110075372.0A external-priority patent/CN112754731A/zh
Priority claimed from CN202110076939.6A external-priority patent/CN112754732B/zh
Application filed by 上海纽脉医疗科技股份有限公司 filed Critical 上海纽脉医疗科技股份有限公司
Priority to KR1020227028838A priority Critical patent/KR20220130209A/ko
Priority to EP21920711.5A priority patent/EP4112008A4/fr
Priority to US17/907,835 priority patent/US20230346546A1/en
Publication of WO2022156335A1 publication Critical patent/WO2022156335A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0061—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof swellable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008—Fixation appliances for connecting prostheses to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0073—Quadric-shaped
    • A61F2230/0076—Quadric-shaped ellipsoidal or ovoid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0069—Sealing means

Definitions

  • the invention relates to the field of medical devices, in particular to an interventional artificial heart valve and a medical device for improving the function of the heart valve.
  • TMVR transcatheter mitral valve replacement surgery
  • TMVR adopts the method of catheter intervention, which compresses the artificial valve to the delivery system in vitro, delivers it to the mitral valve annulus of the human body, and releases and fixes the artificial valve in the human mitral valve annulus. Replace the native valve at the mitral valve annulus.
  • TMVR does not require extracorporeal circulation auxiliary devices, has less trauma, quicker recovery of patients, and significantly improved postoperative hemodynamic indicators.
  • Interventional prosthetic heart valves in which annular support elements combine valve stents with valve leaflets have been reported. Such interventional prosthetic heart valves can better hold the leaflet tissue after implantation and eliminate blood regurgitation. The use of barbs can disrupt the normal physiological function of the human valve leaflets after implantation.
  • the invention discloses an interventional artificial heart valve and a medical device, aiming at solving the technical problems existing in the prior art.
  • an interventional artificial heart valve comprising a valve support and an anchoring portion, the valve support has a body section and a skirt section at an inflow end; a valve leaflet is arranged in the body section; the valve support can be in a radially collapsed configuration with The radially expanding configurations are radially collapsible and expandable; at least a portion of the outer surface of the skirt segment is covered with a flexible annular seal, the flexible annular seal comprising a material capable of absorbing blood; the blood absorbing material expands after absorbing the blood; At least two connecting elements are disposed on one side of the outflow end of the body segment; the anchoring part is disposed around the outer periphery of the valve support and is detachably connected with the connecting elements; the anchoring part includes at least two anchors.
  • the material capable of absorbing blood is a mixture of one or more of PET fibers, polyester fibers, and polyamide fibers.
  • the flexible annular seal also covers a partial area on the side of the inflow end of the body segment.
  • the body segment includes a constraining portion, and the constraining portion is disposed on one side edge of the inflow end of the body segment, for constraining the intrusion of the flexible annular seal into the inner space of the valve stent.
  • the anchor has a circular arc-shaped section, and the free end of the circular arc-shaped section has a connecting portion.
  • both the arc-shaped section and the connecting portion of the anchor are hollow tubes.
  • the anchor has a circular arc-shaped section, an auxiliary section and a connecting part; the free end of the circular arc-shaped section has a connecting part, and the connecting part can be detachably connected with the connecting element; the auxiliary section is connected to the circular arc-shaped section.
  • the anchoring part can be connected with the connecting element, the anchoring part is arranged around the periphery of the valve support after the connection, and the auxiliary section is arranged close to the outflow end and the side of the body section relative to the arcuate section.
  • the body segment includes a plurality of circumferentially arranged supports; the supports extend radially outward and towards the inflow end.
  • the support portion includes a circumferentially arranged first support portion band and a second support portion band, the first support portion band being closer to the inflow end side than the second support portion band.
  • the arcuate section is located in the area substantially enclosed by the first support strip; the auxiliary section is located in the area substantially enclosed by the first support strip or the second support strip.
  • the auxiliary section includes a circular arc-shaped auxiliary section and a connecting section at both ends thereof, the connecting section is connected with the circular arc-shaped section; the auxiliary section is located in an area substantially enclosed by the first support belt.
  • the arc-shaped section includes a plurality of separated sections
  • the auxiliary section includes a plurality of separated sections; the separation section of the arc-shaped section and the separation section of the auxiliary section are connected by a plurality of connecting sections
  • the circular arc section, the auxiliary section and the connecting section are all hollow pipe parts; the auxiliary section is located in the area substantially enclosed by the first support belt.
  • the auxiliary section includes a circular arc-shaped auxiliary section and connecting sections at both ends thereof, the connecting section is connected with the circular arc-shaped section; the auxiliary section is located in the area substantially enclosed by the second support belt.
  • both the arc-shaped section and the connecting portion of the anchor are hollow tubes.
  • the first support strip and/or the second support strip each have a converging portion near the two connecting elements, and the support portion of the converging portion is other than the first support strip and the second support strip.
  • the support portion converges relatively radially.
  • a first connecting element and a second connecting element are provided at one side edge of the outflow end of the body segment, the first connecting element has a first connecting column and a second connecting column, and the second connecting element has a third connecting column and a fourth connecting column column;
  • the anchoring part includes a first anchor and a second anchor, the connecting part of the first anchor includes a first plug-in port and a second plug-in port, and the connection part of the second anchor includes a third plug-in port and a fourth plug-in port
  • the first plug-in port, the second plug-in port, the third plug-in port, and the fourth plug-in port can be inserted into the first connection post, the second connection post, the third connection post and the fourth connection post respectively.
  • the first plug-in port, the second plug-in port, the third plug-in port, the fourth plug-in port, and/or the first connection post, the second connection post, the third connection post, and the fourth connection post have anti-loosening structure.
  • the anti-releasing structure includes one or more combinations of pawls, ratchets, grooves, flanges, and snaps.
  • the first connecting column, the second connecting column, the third connecting column and the fourth connecting column are all hollow cylinders.
  • an interventional artificial heart valve comprising a valve support and an anchoring portion
  • the valve support has a body section and a skirt section at an inflow end; a valve leaflet is arranged in the body section; the valve support can be radially collapsed in a configuration radially collapsing and expanding from the radially expanded configuration; at least two connecting elements are provided on one side of the outflow end of the body segment; the body segment includes a plurality of circumferentially arranged supports; at least some of the supports are radially outward and toward the inflow the end direction extends; the anchoring part includes at least two anchors; the anchoring part has a circular arc-shaped section, an auxiliary section and a connecting part; the free end of the circular arc-shaped section has a connecting part, and the connecting part can be detachably connected with the connecting element connection; the auxiliary section is connected to the arc-shaped section for constraining the human heart valve; the anchoring part can be connected with the connecting element, and after the
  • a medical device for improving the function of a heart valve comprising a valve support and an anchoring portion, the valve support has a body section and a skirt section at the inflow end; a valve leaflet is arranged in the body section; the valve support can radially collapsible and expandable between a radially collapsed configuration and a radially expanded configuration; at least a portion of the outer surface of the skirt segment is covered with a flexible annular seal, the flexible annular seal includes a material capable of absorbing blood; a material that absorbs blood Expand after absorbing blood; at least two connecting elements are arranged on one side of the outflow end of the body segment; the valve stent can be placed in the catheter in a radially collapsed state; the anchoring part includes at least two anchors, and the anchors include a circular arc-shaped area The connecting part of the segment and the free end of the arc-shaped segment; the connecting part can be detachably connected with the connecting element; the anchoring part has elasticity
  • the anchor has a circular arc-shaped section, an auxiliary section and a connecting part; the free end of the circular arc-shaped section has a connecting part, and the connecting part can be detachably connected with the connecting element; the auxiliary section is connected to the circular arc-shaped section.
  • the segment is used for restraining the human heart valve; the anchoring part can be connected with the connecting element, the anchoring part is arranged around the periphery of the valve support after the connection, and the auxiliary segment is close to the outflow end and close to the side of the body segment relative to the arc-shaped segment set up.
  • the body segment has a retracted region on the side close to the outflow end.
  • an internal sealing membrane is provided inside the valve support.
  • the skirt segment is a trumpet-shaped structure
  • the body segment is substantially cylindrical
  • the small diameter end of the trumpet-shaped structure of the skirt segment is connected to the body part
  • the outer peripheral edge of the flared structure has a downturned structure for increased anchoring to the native annulus.
  • the cross section of the body segment and/or the skirt segment is a D-shaped or elliptical closed loop surrounded by a plurality of convex curves.
  • the valve stent structure and the connecting structure with the anchoring part are improved at the same time, and it is suitable for transcatheter implantation into the left atrium or right atrium of the human heart to replace the diseased mitral valve or tricuspid valve.
  • the valve performs functions. After implantation, it will not cause damage to the normal physiological function of the human valve leaflets, and has a certain restriction on the expansion of the valve annulus. At the same time, it can also reduce outflow tract obstruction and promote postoperative rehabilitation of patients.
  • the flexible annular seal is made of materials that can absorb blood.
  • the flexible annular seal absorbs blood and gradually expands, swells, and thickens to fully fill the valve stent and skirt segment with the human heart valve and human valve.
  • the space between the rings can give proper compression to human tissue to avoid or reduce the occurrence of paravalvular leakage.
  • the auxiliary section can produce a synergistic effect with the support band to ensure the stability of the anchor, and at the same time, it can further lift the human heart valve to reduce outflow tract obstruction.
  • FIG. 1 is a schematic structural diagram of a valve stent for an interventional artificial heart valve disclosed in Embodiment 1 of the present invention
  • FIG. 2 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 1 of the present invention.
  • FIG. 3 is a schematic plan view of the valve stent of the interventional artificial heart valve disclosed in Embodiment 1 of the present invention.
  • FIG. 4A is a schematic plan view of a valve stent for an interventional artificial heart valve disclosed in Embodiment 1 of the present invention.
  • FIG. 4B is a schematic plan view of another embodiment of the valve stent for the interventional artificial heart valve disclosed in Example 1 of the present invention.
  • FIG. 5 is a top view of the valve stent of the interventional artificial heart valve disclosed in Embodiment 1 of the present invention.
  • FIG. 6 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 2 of the present invention.
  • FIG. 7 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 2 of the present invention.
  • FIG. 8 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 3 of the present invention.
  • FIG. 9 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 3 of the present invention.
  • FIG. 10 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 3 of the present invention.
  • FIG. 11 is a schematic diagram of the combined structure of the interventional artificial heart valve disclosed in Embodiment 4 of the present invention.
  • FIGS. 12A and 12B are schematic diagrams of the combined structure of the interventional artificial heart valve disclosed in Embodiment 5 of the present invention.
  • FIG. 13 is a schematic diagram of the state during the implantation of the interventional prosthetic heart valve disclosed in Embodiment 6 of the present invention.
  • FIG. 14 is a schematic diagram of the implantation of the interventional artificial heart valve disclosed in Embodiment 6 of the present invention into the heart;
  • FIG. 15 is a schematic diagram of the implantation of the interventional artificial heart valve disclosed in Embodiment 6 of the present invention into the heart.
  • Valve stent 1 body segment 10; support part 11; first support part band 111; second support part band 112; converging parts 1111, 1121; ; retracted area 14; flexible annular seal 15; first connecting element 16; second connecting element 17; first connecting column 161, second connecting column 162, third connecting column 171, fourth connecting column 172;
  • Anchoring part 2 first anchor 21; second anchor 22; first socket 211, second socket 212, third socket 221, fourth socket 222; arc-shaped section 23; structure 24; auxiliary section 25; connecting section 26; guide wire 30.
  • the terms “installed”, “connected” and “connected” should be understood in a broad sense, unless otherwise expressly specified and limited, for example, it may be a fixed connection or a detachable connection Connection, or integral connection; can be mechanical connection, can also be electrical connection; can be directly connected, can also be indirectly connected through an intermediate medium, can be internal communication between two elements.
  • installed should be understood in a broad sense, unless otherwise expressly specified and limited, for example, it may be a fixed connection or a detachable connection Connection, or integral connection; can be mechanical connection, can also be electrical connection; can be directly connected, can also be indirectly connected through an intermediate medium, can be internal communication between two elements.
  • outflow tract refers to the left ventricular outflow tract when the interventional prosthetic heart valve 500 is a mitral valve, and refers to the left ventricular outflow tract when the interventional prosthetic heart valve 500 is a tricuspid valve is the right ventricular outflow tract.
  • substantially enclosed refers to an open space enclosed by an open surface rather than an enclosed space enclosed by a complete surface.
  • substantially annular may refer to a generally annular shape composed of a plurality of components, and is not limited to a closed loop, nor is it limited to a standard circular loop.
  • the present Example 1 provides an interventional artificial heart valve 500, which mainly includes a substantially annular anchoring portion 2 disposed near the natural valve annulus tissue, and a valve stent 1 provided with artificial valve leaflets.
  • the upper inflow end of the valve support 1 is provided with an atrial flange for engaging with the human valve annulus 300 .
  • the valve support 1 has a body section 10 and a skirt section 120 at the inflow end; preferably
  • the skirt section 120 is a trumpet-shaped structure, the body section 10 is substantially cylindrical, and the smallest diameter end of the trumpet-shaped structure of the skirt section 120 is connected to the body section 10 .
  • the preferred body segment 10 includes interconnected or interwoven longitudinal and transverse skeletons. In preferred embodiments, the transverse skeletons can be replaced by other structures to provide better radial collapse performance while performing other functions. specific discussion in the text.
  • a valve leaflet 13 is provided in the body section 10; the valve leaflet 13 preferably has two or three artificial valve leaflets, the artificial valve leaflets are attached to the struts of the valve support 1, and the valve support 1 is provided with an internal seal membrane to prevent paravalvular leakage.
  • the interventional prosthetic heart valve 500 in this embodiment 1 all needs to be delivered through a catheter, so the valve stent 1 can be radially collapsed and expanded between a radially collapsed configuration and a radially expanded configuration.
  • At least two connecting elements are provided on one side of the outflow end of the body segment 10; the lower end of the valve support 1 is provided with a corresponding number of connecting portions protruding radially outward for receiving the connecting elements on the annular anchor.
  • the anchoring part 2 is arranged around the periphery of the valve support 1 and is detachably connected with the connecting element; the anchoring part 2 includes at least two anchoring parts, that is, the anchoring part 2 has at least two separate sections. After a plurality of segments, in other words a plurality of anchors are correspondingly connected to the connecting element, these anchors can form a substantially annular shape. Those skilled in the art should understand that there is no gap between the anchors, but a gap is allowed, and a small gap will not affect the effect of Embodiment 1, and will not bring about problems such as reflux.
  • the annular anchoring portion 2 is placed in the ventricle 100, below the human valve annulus 300, on the periphery of the human heart valve 200, and an interference fit is formed between the anchoring portion 2 and the valve support 1, which can effectively prevent the interventional artificial
  • the heart valve 500 remains in the desired implantation position.
  • At least part of the outer surface of the skirt segment 120 is covered with a flexible annular seal 15, and the flexible annular seal 15 includes a material capable of absorbing blood; preferably, the flexible annular seal 15 also covers the side of the inflow end of the body segment 10. partial area.
  • the material capable of absorbing blood is a mixture of one or more of PET fibers, polyester fibers, and polyamide fibers. Since the flexible annular seal 15 is made of a material that can absorb blood, during the implementation of the interventional operation, after the flexible annular seal 15 enters the human heart through the catheter, it covers part of the human heart valve 200 and part of the human valve annulus 300. After contacting with blood, the above-mentioned material capable of absorbing blood will gradually absorb blood, and undergo morphological changes such as expansion, swelling and thickening within minutes to tens of minutes.
  • the flexible annular sealing member 15 gradually expands, expands and thickens, and fully fills the gap between the valve stent 1 and the skirt segment 120 and the human heart valve 200 and the human valve annulus 300. space, and give proper compression to human tissue to avoid or reduce the occurrence of paravalvular leakage. Moreover, since the holding force is applied to the valve annulus and/or the human heart valve 200 through the flexible annular seal 15, the pressure is applied relatively uniformly, which further avoids or reduces the damage to the human tissue caused by the valve stent 1.
  • the anchor and valve stent 1 are preferably made of shape memory alloy, preferably Nitinol alloy, so as to be delivered to the human heart valve 200 through a catheter in a compressed form, and expanded to a position after being released by the catheter sheath. predetermined form.
  • shape memory alloy preferably Nitinol alloy
  • the outer surface of the annular anchor is covered with a film made of PET, PTFE or polyurethane material, which reduces the damage to the captured valve leaflet tissue and facilitates the process of endothelialization.
  • the body segment 10 includes a plurality of circumferentially arranged support portions 11 ; the support portions 11 extend radially outward and toward the inflow end.
  • the support portion 11 is substantially a "herringbone"-shaped structure, two bottom ends of the structure are respectively connected with the vertical frame of the body section 10, and the top end of the structure is an arc.
  • the body segment 10 is not provided with a transverse skeleton, and a plurality of “herringbone” shaped support parts 11 evenly distributed in the circumferential direction of the body segment 10 serve as part of the transverse skeleton to support the radial structure of the body segment 10 .
  • the included angle between the plane where the main body of the support part 11 (ie the top and middle part of the "herringbone”-shaped structure) is located and the body section 10 where it is connected is 30-60 degrees, preferably 50 degrees. It will be appreciated that to some extent the plurality of supports 11 together with the skirt segments 120 define an interior channel for receiving the anchors 2 . By arranging the cooperation between the skirt portion 120 and the support portion 11 , the anchoring stability of the interventional prosthetic heart valve 500 is ensured, and displacement after implantation is avoided to a certain extent.
  • the support portion 11 includes a first support portion band 111 and a second support portion band 112 arranged in the circumferential direction, and the first support portion band 111 is closer to the inflow end side than the second support portion band 112 .
  • the first support portion band 111 and the second support portion band 112 each have a structure of six support portions 11 .
  • the second support band 112 is close to the outflow end of the lower part of the valve support 1 , and can play the function of clamping the valve leaflets to a certain extent, and is used to fold and clamp the valve leaflet tissue.
  • the leaflet tissue is captured and retained within the first support band 111 and the second support band 112 , thereby increasing the outflow tract by lifting the leaflet tissue up near the outflow tract of the ventricle 100 .
  • the effective outflow area nearby can achieve the effect of reducing outflow tract obstruction.
  • the second support belt 112 has a converging portion 1121 at a position close to the first connecting element 16 and the second connecting element 17 .
  • the most important part of the second support belt 112 is One support portion 11 close to the first connecting element 16 and the other support portion 11 closest to the second connecting element 17 are respectively two converging portions 1121 .
  • the support portion 11 of the converging portion 1121 is relatively radially convergent compared to the other support portions 11 of the second support portion band 112 .
  • the converging portion 1121 extends towards the inflow end and does not extend radially outward.
  • the first support strip 111 and the second support strip 112 have converging parts 1111 and 1121 at positions close to the first connecting element 16 and the second connecting element 17 , Specifically, the one supporting portion 11 of the first supporting portion band 111 closest to the first connecting element 16 and the other supporting portion 11 closest to the second connecting element 17 are respectively two converging portions 1111; the second supporting portion The one support portion 11 of the belt 112 closest to the first connecting element 16 and the other support portion 11 closest to the second connecting element 17 are respectively two converging portions 1121 .
  • the support portion 11 of the converging portion 1121 is relatively radially convergent compared to the other support portions 11 of the second support portion band 112 .
  • the converging portion 1121 extends towards the inflow end and does not extend radially outward.
  • This embodiment can avoid the interference between the anchoring part 2 and the valve stent 1 to the greatest extent, avoid the anchoring part 2 being hooked on the supporting part 11 of the valve stent 1 during the operation, and reduce the difficulty of operation.
  • the first connecting element 16 and the second connecting element 17 have a smaller radially outward extension than the embodiment shown in FIG. 4A , so that the The anchoring portion 2 enhances the anchoring effect on the human heart valve 200 .
  • the body segment 10 includes a constraining portion 12 , and the constraining portion 12 is disposed on one side edge of the inflow end of the body segment 10 for constraining the flexible annular seal 15 from invading the inner space of the valve stent 1 .
  • the restraint portion 12 includes a plurality of transverse restraint frames. The transverse restraint frames are roughly in the shape of a "herringbone" shape.
  • the two bottom ends of the structure are respectively connected to the top ends of the inflow ends of the vertical skeleton of the body section 10.
  • the top ends of the structures are arcs.
  • the "herringbone"-shaped structure of the lateral restraint frame can optimize the collapsible performance of the valve stent 1 .
  • the anchor has a circular arc section 23 , and the free end of the circular arc section 23 has a connecting portion.
  • the corresponding two free ends of each segment are provided with connecting elements for connecting to the valve support 1 .
  • the arc-shaped section 23 and the connecting portion of the anchor are both hollow tubes.
  • the arcuate section 23 has a larger diameter than the connecting portion, so as to increase the contact area of the anchor with human tissue, thereby increasing the stability of the anchor and reducing the risk of damage to the human tissue.
  • a first connecting element 16 and a second connecting element 17 are provided at one edge of the outflow end of the body segment 10 , and the first connecting element 16 has a first connecting column 161 and a second connecting column 162 .
  • the two connecting elements 17 have a third connecting column 171 and a fourth connecting column 172;
  • the anchoring part 2 includes a first anchor 21 and a second anchor 22, and the connecting part of the first anchor 21 includes a first socket 211 and a second
  • the plug port 212, the connecting portion of the second anchor 22 includes a third plug port 221 and a fourth plug port 222; the first plug port 211, the second plug port 212, the third plug port 221, and the fourth plug port 222 can respectively Insert the first connection post 161 , the third connection post 171 , the second connection post 162 , and the fourth connection post 172 .
  • first plug-in port 211, the second plug-in port 212, the third plug-in port 221, the fourth plug-in port 222, and/or the first connection post 161, the second connection post 162, the third connection The post 171 and the fourth connection post 172 have the anti-releasing structure 24 .
  • the anti-releasing structure 24 includes a combination of one or more of pawls, ratchets, grooves, flanges, and buckles to ensure the stability of the connection.
  • the anti-releasing structure 24 can be selected from any similar anti-releasing structure 24 existing in the art, which is not limited in this application.
  • the first connection column 161, the second connection column 162, the third connection column 171, and the fourth connection column 172 are all hollow cylinders.
  • the outer peripheral edge of the flared structure of the skirt segment 120 has a downturned structure 121 for increasing the anchoring effect with the native valve annulus.
  • the downturned structure 121 can cooperate with the anchoring portion 2 to form a locking effect, thereby further improving the anchoring stability.
  • the trumpet-shaped structure of the skirt section 120 includes 6 petal-shaped skeletons, and each petal-shaped skeleton includes a first section extending outwardly and upwardly from the top of the body section 10 , and a second section extending outwardly and downwardly. It should be understood that the downturned structure 121 corresponds to the above-mentioned second segment of the petal-shaped skeleton.
  • the petal-like skeleton gradually shrinks in size as it extends outward.
  • “outside” means the direction outward from the center of the horn-like structure
  • “up” means the direction close to the inflow end
  • “down” means the direction close to the outflow end.
  • the cross section of the body section 10 and/or the skirt section 120 is a D-shaped or elliptical closed loop surrounded by a plurality of convex curves, so as to better match the structure of the human valve annulus 300 .
  • the interventional prosthetic heart valve 500 of the present embodiment 1 improves the structure of the valve support 1 and the connection mechanism between the valve support 1 and the anchoring portion 2 on the basis of using the non-closed annular anchoring portion 2, and is suitable for transcatheter implantation into the human body
  • the left atrium or right atrium of the heart replaces the diseased mitral valve or tricuspid valve to perform functions. After implantation, it will not cause damage to the normal physiological function of the human valve leaflets, and has a certain restriction on the expansion of the valve annulus. Reduce outflow tract obstruction and promote postoperative recovery of patients.
  • This embodiment 2 provides an interventional artificial heart valve 500 , which is different from the first embodiment in that the specific structure of the anchoring portion 2 in this embodiment 2 is shown in FIGS. 6 and 7 .
  • the anchor includes a circular arc section 23 , an auxiliary section 25 and a connecting part; the auxiliary section 25 is connected to the circular arc section 23 .
  • the free end of the circular arc-shaped section 23 has a connecting portion which can be detachably connected to a connecting element.
  • the auxiliary section 25 is likewise in the shape of a circular arc, the size of which is smaller than that of the circular arc section 23 .
  • the auxiliary section 25 is connected with the circular arc section 23 by two connecting sections 26 at both ends; the circular arc section 23 , the auxiliary section 25 and the connecting section 26 are all located in the area substantially enclosed by the first support belt 111 .
  • the arc-shaped section 23 has a larger diameter than the connecting portion, and preferably the diameter of the arc-shaped section 23 is 1.5-2.5 times the diameter of the connecting portion, so as to increase the contact area between the anchor and human tissue. Anchoring stability while reducing the risk of damage to human tissue.
  • the arcuate section 23 is located in the area substantially enclosed by the first support strip 111 ; the auxiliary section 25 is also located in the area substantially enclosed by the first support strip 111 .
  • the auxiliary section 25 includes an arc-shaped auxiliary section and connecting sections 26 at both ends thereof, and the connecting sections 26 are connected with the arc-shaped section 23 .
  • the arc-shaped section 23 and the connecting parts at both ends thereof are both hollow tubular, and a connected and smooth cavity is formed inside, allowing the guide wire 30 to pass through.
  • the auxiliary section 25 is preferably a hollow tubular shape or a solid cylindrical shape, and even if it is a hollow tubular shape, its inner cavity is not communicated with the inner cavity of the circular arc section 23, and the guide wire 30 is not allowed to enter.
  • the circular arc-shaped section 23 has a larger diameter than the auxiliary section 25 , preferably the diameter of the circular arc-shaped section 23 is 1.5-2.5 times the diameter of the auxiliary section 25 . And the arc-shaped section 23 has greater structural strength than the auxiliary section 25 .
  • the auxiliary section 25 can constrain (compress) the human heart valve 200 in the first support band 111 closer to the inflow end, so that the human heart valve 200 can be further lifted up and the outflow tract can be further lowered. obstruction.
  • the auxiliary section 25 can also produce a synergistic effect with the first support band 111.
  • the auxiliary section 25 can give a circular shape to a certain extent. The arcuate section 23 supports the force and ensures the stability of the anchor.
  • the specific structure of the anchoring portion 2 in the third embodiment is different from that of the second embodiment, and the valve stent 1 in this embodiment is not different from the first and second embodiments.
  • the anchor has a generally arcuate section 23, the free end of which has a connecting portion. The corresponding two free ends of each segment are provided with connecting elements for connecting to the valve support 1 .
  • the arc-shaped section 23 of the anchor and the connecting portion are both hollow tubes.
  • the arc-shaped section 23 has a larger diameter than the connecting part, and preferably the diameter of the arc-shaped section 23 is 1.5-2.5 times the diameter of the connecting part, so as to increase the contact area between the anchor and the human tissue and increase the stability of the anchor. while reducing the risk of damage to human tissues.
  • the arc-shaped section 23 includes a plurality of separate sections
  • the auxiliary section 25 includes a plurality of separate sections; the separation section of the arc-shaped section 23 and the separation of the auxiliary section 25
  • the sections are connected as a whole by a plurality of connecting sections 26; the arc-shaped section 23, the auxiliary section 25 and the connecting section 26 are all hollow pipes; within the combined area.
  • the arc-shaped section 23 , the auxiliary section 25 , the connecting section 26 and the connecting parts at both ends thereof are all hollow tubular, and a connected and smooth cavity is formed inside, allowing the guide wire 30 to pass through.
  • the circular arc-shaped section 23 and the auxiliary section 25 have the same diameter, and are preferably made of the same material in one piece.
  • the auxiliary section 25 includes two separate sections, and the positions of the two sections are the same as the positions of the two support sections 11 of the first support section band 111 in the state where the valve stent 1 is connected to the anchor section 2 . corresponding to produce a synergistic effect.
  • the connecting segment 26 is preferably not perpendicular to the arcuate segment 23 and the auxiliary segment 25 , and the sum of the included angle between the connecting segment 26 and the arcuate segment 23 and the auxiliary segment 25 is 180 degrees.
  • the length of the separation section of the auxiliary section 25 is longer than the length of the gap between the plurality of sections of the arcuate section 23 .
  • the auxiliary section 25 can constrain (press) the human heart valve 200 in the first support band 111 closer to the inflow end, so that the human heart valve 200 Further raised to further reduce the obstruction of the outflow tract, the auxiliary section 25 can also produce a synergistic effect with the first support band 111 .
  • the structure in which the anchor is integrally formed is also easier to manufacture and can provide better reliability.
  • the anchoring portion 2 in the fourth embodiment is different from that of the first and second embodiments.
  • the anchor includes a circular arc section 23 , an auxiliary section 25 and a connecting part; the auxiliary section 25 is connected to the circular arc section 23 .
  • the free end of the circular arc-shaped section 23 has a connecting portion which can be detachably connected to a connecting element.
  • the auxiliary section 25 is likewise in the shape of a circular arc, the size of which is smaller than that of the circular arc section 23 .
  • the auxiliary section 25 is connected to the circular arc section 23 by two connecting sections 26 at both ends; according to FIG. 11 , the circular arc section 23 is located in the area substantially enclosed by the first support belt 111 , while the auxiliary section 25 Located in the area substantially enclosed by the second support band 112 .
  • the arc-shaped section 23 has a larger diameter than the connecting portion, and preferably the diameter of the arc-shaped section 23 is 1.5-2.5 times the diameter of the connecting portion, so as to increase the contact area between the anchor and human tissue. Anchoring stability while reducing the risk of damage to human tissue.
  • the auxiliary section 25 is arc-shaped, and is connected to the arc-shaped section 23 by connecting sections 26 at both ends.
  • the length of the connecting section 26 in Embodiment 4 is longer, and both ends of each connecting section 26 span the first support belt 111 and the second support belt 112 .
  • the auxiliary section 25 and the connecting section 26 connected at both ends are connected to the circular arc section 23 across the two supporting parts 11 of the first supporting part belt 111 .
  • the arc-shaped section 23 and the connecting parts at both ends thereof are both hollow tubular, and a connected and smooth cavity is formed inside, allowing the guide wire 30 to pass through.
  • the auxiliary section 25 is preferably a hollow tubular shape or a solid cylindrical shape, and even if it is a hollow tubular shape, its inner cavity is not communicated with the inner cavity of the circular arc section 23, and the guide wire 30 is not allowed to enter.
  • the circular arc-shaped section 23 has a larger diameter than the auxiliary section 25 , preferably the diameter of the circular arc-shaped section 23 is 1.5-2.5 times the diameter of the auxiliary section 25 . And the arc-shaped section 23 has greater structural strength than the auxiliary section 25 .
  • the auxiliary section 25 can constrain (compress) the human heart valve 200 in the second support band 112 closer to the inflow end, so that the human heart valve 200 can be further lifted up and the outflow tract can be further lowered. obstruction. Meanwhile, since the second support band 112 is relatively closer to the chordae tendineae 400, the anchor structure can restrain the free end of the human heart valve 200 and the chordae tendineae 400 to a certain extent, thereby minimizing outflow tract obstruction.
  • the artificial heart valve 500 has a first anchor 21 and a second anchor 22, wherein the first anchor 21 has the anchor structure in Example 4, and is connected near the inflow end of the aortic valve while the second anchor 22 has the anchor structure in Embodiment 2 or 3, and is connected to the other side away from the aortic valve.
  • This embodiment provides stable anchoring while reducing outflow tract obstruction.
  • This example 5 provides an interventional prosthetic heart valve 500.
  • the valve stent 1 is of asymmetrical design as a whole, and the outflow end of the body segment 10 corresponds to The part of the outflow tract of the ventricle 100 is offset in the direction away from the outflow tract, that is, the body section 10 has a retracted area 14 on the side near the outflow end, so as to further reduce the influence on the outflow tract.
  • the preferred location of the retracted region 14 should avoid the positions of the first connecting element 16 and the second connecting element 17 .
  • the retracted region 14 is preferably arranged at an equidistant position from the first connecting element 16 and the second connecting element 17 to minimize the impact on the outflow channel.
  • the first anchor 21 and the second anchor 22 should also be set to different structures, corresponding to the anchor on the side of the retracted region 14 (with the first anchor 22 ).
  • Anchor 21 for example
  • Anchor 21 has a smaller size.
  • the arc-shaped section 23 of the first anchor 21 is shorter than the arc-shaped section 23 of the second anchor 22.
  • the first socket 211, the second socket 212, the third socket 221, The shape and size of the fourth socket 222 may not be changed.
  • Embodiment 6 the implantation process of the interventional prosthetic heart valve 500 of Embodiments 1-5 will be described with reference to FIGS. 13-15 .
  • a plurality of guide wires 30 are arranged under the tissue of the human valve annulus 300, and the first anchor 21 and the second anchor 22 of the anchor portion 2 are moved along the pre-arranged guide wires 30 by the first delivery device. Delivered to the implantation site and released, each guide wire 30 is threaded through the connecting elements at both ends of the first anchor 21 and the second anchor 22, respectively.
  • the guide wire 30 is passed through the corresponding connecting parts on the valve support 1 , such as the first connecting post 161 of the first connecting element 16 , the third connecting post 171 of the second connecting element 17 , and the first connecting post 161 of the first connecting element 16 .
  • the second connection post 162, the fourth connection post 172 of the second connection element 17, and the valve stent 1 in a compressed state is delivered into the heart by means of the second delivery device.
  • the guide wire 30 to complete the connection between the connecting elements on the annular anchor and the corresponding connecting parts.
  • the first plug-in port 211, the second plug-in port 212, the third plug-in port 221, and the fourth plug-in port 222 are respectively inserted into the first connection
  • the post 161 , the third connection post 171 , the second connection post 162 , and the fourth connection post 172 are fastened and connected by the anti-releasing structure 24 .
  • valve stent 1 is expanded to capture the natural valve leaflets and form a tight fit with the annular anchor to complete the implantation procedure.
  • the flexible annular seal 15 covers the partial area of the human heart valve 200 and the partial area of the valve annulus.
  • the material capable of absorbing the blood will gradually absorb the blood.
  • Morphological changes such as expansion, expansion, and thickening continue to occur within ten minutes, and finally the flexible annular seal 15 gradually expands, expands, and thickens to fully fill the valve stent 1 and the skirt segment 120 and the human heart valve 200 and the human valve annulus 300.
  • a plurality of guide wires 30 are arranged under the tissue of the human valve annulus 300, and the first anchor 21 and the second anchor 22 of the anchor portion 2 are moved along the pre-arranged guide wires 30 by the first delivery device. Delivered to the implantation site and released, each guide wire 30 is threaded through the connecting elements at both ends of the first anchor 21 and the second anchor 22, respectively.
  • the process of passing the guide wire 30 through the first anchor 21 and the second anchor 22 will vary according to different anchor structures.
  • the guide wire 30 only needs to pass through the hollow tubular body of the arc-shaped section 23 .
  • the arc-shaped section includes a plurality of separated sections
  • the auxiliary section 25 also includes a plurality of separated sections; the separation section of the arc-shaped section and the auxiliary section 25
  • the separation section is connected as a whole by a plurality of connecting sections; the arc-shaped section, the auxiliary section 25 and the connecting section are all hollow tubes, it should be understood that the guide wire 30 needs to pass through the first anchor 21 and the second anchor 22 for all segments of the cavity.
  • the first anchor 21 and the second anchor 22 are preferably stretched to reduce their bending and make their inner cavity as smooth as possible to facilitate the threading operation.
  • the guide wire 30 is passed through the corresponding connecting parts on the valve support 1 , such as the first connecting post 161 of the first connecting element 16 , the third connecting post 171 of the second connecting element 17 , and the first connecting post 161 of the first connecting element 16 .
  • the second connection post 162, the fourth connection post 172 of the second connection element 17, and the valve stent 1 in a compressed state is delivered into the heart by means of the second delivery device.
  • the guide wire 30 to complete the connection between the connecting elements on the annular anchor and the corresponding connecting parts.
  • the first plug-in port 211, the second plug-in port 212, the third plug-in port 221, and the fourth plug-in port 222 are respectively inserted into the first connection
  • the post 161 , the third connection post 171 , the second connection post 162 , and the fourth connection post 172 are fastened and connected by the anti-releasing structure 24 .
  • valve stent 1 is expanded to capture the natural valve leaflets and form a tight fit with the annular anchor to complete the implantation procedure.
  • This embodiment 7 provides a medical device for improving the function of a heart valve, which can be understood as a medical set for improving the function of a heart valve.
  • the medical device or medical suit mainly includes two parts, namely, the valve support 1 and the anchoring part 2 .
  • the device or kit may also include a catheter and/or guide wire 30 .
  • the valve stent 1 has a body segment 10 and a skirt segment 120 at the inflow end; the body segment 10 is provided with a valve leaflet 13; the valve stent 1 can radially collapse and expand between a radially collapsed configuration and a radially expanded configuration; At least part of the outer surface of the skirt section 120 is covered with a flexible annular seal 15, and the flexible annular seal 15 includes a material capable of absorbing blood; the material absorbing blood expands after absorbing the blood; at least two connecting element; the valve stent 1 can be placed in the catheter in a radially collapsed state;
  • the anchoring part 2 includes at least two anchors 21, 22, the anchors 21, 22 include a circular arc-shaped section 23 and a connecting part of the free end of the circular arc-shaped section 23; the connecting part can be detachable from the connecting elements 16, 17 Connection; the anchoring part 2 has elasticity and can be placed in the catheter after elastic deformation.
  • both the valve stent 1 and the anchoring portion 2 can be provided in a radially collapsed state or a radially expanded state before the interventional operation is performed.
  • an operation manual may be included, and the implantation method and steps described in the above Embodiment 7 may be described in the operation manual.
  • valve stent 1 and the anchoring portion 2 For the specific structures of the valve stent 1 and the anchoring portion 2, refer to all the features described in Embodiments 1-5 of this specification.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne une prothèse valvulaire cardiaque interventionnelle (500) et un appareil médical. La prothèse valvulaire cardiaque interventionnelle comprend un stent valvulaire (1) et une partie d'ancrage (2) ; le stent valvulaire (1) comprend une section corps (10) et une section jupe (120) au niveau d'une extrémité d'entrée ; la section corps (10) est pourvue à l'intérieur d'une partie feuillet de valvulaire (13) ; au moins une partie de la surface extérieure de la section jupe (120) est recouverte par un élément d'étanchéité annulaire souple (15) ; l'élément d'étanchéité annulaire souple (15) comprend un matériau capable d'absorber le sang ; au moins deux éléments de raccordement (16, 17) sont disposés sur le côté d'une extrémité de sortie de la section corps (10) ; la partie d'ancrage (2) est disposée autour de la périphérie du stent valvulaire (1) et raccordée de façon détachable aux éléments de raccordement (16, 17). Une partie d'ancrage annulaire non fermée (2) est utilisée, de telle sorte que la prothèse valvulaire cardiaque interventionnelle est appropriée pour une implantation transcathéter dans l'oreillette gauche ou l'oreillette droite d'un cœur humain de façon à remplacer une valvule bicuspide ou une valvule tricuspide malade pour en exécuter la fonction, et l'implantation n'entraîne aucune détérioration des fonctions physiologiques normales des feuillets valvulaires humains, et un certain effet de limitation sur l'expansion de tissus annulaires est obtenu ; de plus, l'obstruction des voies de sortie peut être réduite, et la rééducation post-opératoire des patients est facilitée.
PCT/CN2021/131387 2021-01-20 2021-11-18 Prothèse valvulaire cardiaque interventionnelle et appareil médical WO2022156335A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020227028838A KR20220130209A (ko) 2021-01-20 2021-11-18 삽입식 인공 심장 판막 및 의료용 장치
EP21920711.5A EP4112008A4 (fr) 2021-01-20 2021-11-18 Prothèse valvulaire cardiaque interventionnelle et appareil médical
US17/907,835 US20230346546A1 (en) 2021-01-20 2021-11-18 Interventional artificial heart valve and medical apparatus

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202110076939.6 2021-01-20
CN202110075372.0A CN112754731A (zh) 2021-01-20 2021-01-20 一种介入式人工心脏瓣膜及医用装置
CN202110075372.0 2021-01-20
CN202110076939.6A CN112754732B (zh) 2021-01-20 2021-01-20 一种介入式人工心脏瓣膜及医用装置

Publications (1)

Publication Number Publication Date
WO2022156335A1 true WO2022156335A1 (fr) 2022-07-28

Family

ID=82549340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/131387 WO2022156335A1 (fr) 2021-01-20 2021-11-18 Prothèse valvulaire cardiaque interventionnelle et appareil médical

Country Status (4)

Country Link
US (1) US20230346546A1 (fr)
EP (1) EP4112008A4 (fr)
KR (1) KR20220130209A (fr)
WO (1) WO2022156335A1 (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150272737A1 (en) * 2014-03-26 2015-10-01 St. Jude Medical, Cardiology Division, Inc. Transcatheter mitral valve stent frames
US20170079785A1 (en) * 2014-05-22 2017-03-23 St. Jude Medical, Cardiology Division, Inc. Stents with anchoring sections
CN107613907A (zh) * 2015-04-27 2018-01-19 杭州启明医疗器械有限公司 心脏瓣膜组件
CN107690323A (zh) * 2015-04-16 2018-02-13 爱德华兹生命科学公司 用于置换二尖瓣的小外形人工心脏瓣膜
CN111772879A (zh) * 2020-07-15 2020-10-16 上海臻亿医疗科技有限公司 一种人工心脏瓣膜
CN212066943U (zh) * 2019-08-23 2020-12-04 先健科技(深圳)有限公司 心脏瓣膜
CN112089506A (zh) * 2019-06-17 2020-12-18 中国医学科学院阜外医院 瓣膜支架及具有该瓣膜支架的心脏瓣膜
CN112754732A (zh) * 2021-01-20 2021-05-07 上海纽脉医疗科技有限公司 一种介入式人工心脏瓣膜及医用装置
CN112754731A (zh) * 2021-01-20 2021-05-07 上海纽脉医疗科技有限公司 一种介入式人工心脏瓣膜及医用装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072603B2 (en) * 2010-02-24 2015-07-07 Medtronic Ventor Technologies, Ltd. Mitral prosthesis and methods for implantation
US9144663B2 (en) * 2012-10-24 2015-09-29 Medtronic, Inc. Methods and devices for repairing and/or preventing paravalvular leakage post-implantation of a valve prosthesis
US20200121454A1 (en) * 2016-03-01 2020-04-23 Paul A. Spence System, devices and methods for anchoring and/or sealing a heart valve prosthesis
WO2020073056A1 (fr) * 2018-10-06 2020-04-09 Gifford Iii Hanson S Systèmes modulaires de remplacement de valve et dispositifs associés et méthodes d'utilisation

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150272737A1 (en) * 2014-03-26 2015-10-01 St. Jude Medical, Cardiology Division, Inc. Transcatheter mitral valve stent frames
US20170079785A1 (en) * 2014-05-22 2017-03-23 St. Jude Medical, Cardiology Division, Inc. Stents with anchoring sections
CN107690323A (zh) * 2015-04-16 2018-02-13 爱德华兹生命科学公司 用于置换二尖瓣的小外形人工心脏瓣膜
CN107613907A (zh) * 2015-04-27 2018-01-19 杭州启明医疗器械有限公司 心脏瓣膜组件
CN112089506A (zh) * 2019-06-17 2020-12-18 中国医学科学院阜外医院 瓣膜支架及具有该瓣膜支架的心脏瓣膜
CN212066943U (zh) * 2019-08-23 2020-12-04 先健科技(深圳)有限公司 心脏瓣膜
CN111772879A (zh) * 2020-07-15 2020-10-16 上海臻亿医疗科技有限公司 一种人工心脏瓣膜
CN112754732A (zh) * 2021-01-20 2021-05-07 上海纽脉医疗科技有限公司 一种介入式人工心脏瓣膜及医用装置
CN112754731A (zh) * 2021-01-20 2021-05-07 上海纽脉医疗科技有限公司 一种介入式人工心脏瓣膜及医用装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4112008A4 *

Also Published As

Publication number Publication date
US20230346546A1 (en) 2023-11-02
EP4112008A4 (fr) 2024-03-20
KR20220130209A (ko) 2022-09-26
EP4112008A1 (fr) 2023-01-04

Similar Documents

Publication Publication Date Title
US10980632B2 (en) Prosthetic heart valve
US11589985B2 (en) Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US20210315558A1 (en) Devices and methods for delivery of expandable prostheses
US20220233305A1 (en) Prosthetic heart valve having improved commissure supports
KR102583401B1 (ko) 승모 판막 어셈블리
US10231835B2 (en) Replacement heart valve
JP5687070B2 (ja) 人工心臓弁用のステント
CN111973320B (zh) 用于经导管瓣膜的覆盖物和组装方法
CN108578016B (zh) 一种经心尖植入式二尖瓣瓣膜装置
EP3021792B1 (fr) Système de réparation et de remplacement d'une valvule cardiaque
WO2018184225A1 (fr) Bioprothèse valvulaire
JP2020054881A (ja) 僧帽弁プロテーゼ
JP2020049274A (ja) カテーテル案内置換弁装置および方法
JP2020531178A (ja) テザー連結部を有する人工心臓弁
US20190029811A1 (en) Heart valve
CN112754731A (zh) 一种介入式人工心脏瓣膜及医用装置
EP3445280B1 (fr) Dispositifs de fermeture d'orifices d'accès transvasculaire ou transcaméral
EP4262628A1 (fr) Joint d'étanchéité pliable pour valvule cardiaque
CN112754732B (zh) 一种介入式人工心脏瓣膜及医用装置
CN110279495A (zh) 一种自膨胀心脏瓣膜假体
CN216962743U (zh) 一种人工心脏瓣膜及医用装置
CN216962744U (zh) 一种人工心脏瓣膜及医用装置
WO2022156335A1 (fr) Prothèse valvulaire cardiaque interventionnelle et appareil médical
CN218075336U (zh) 二尖瓣瓣膜支架机构

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 20227028838

Country of ref document: KR

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21920711

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021920711

Country of ref document: EP

Effective date: 20220927

NENP Non-entry into the national phase

Ref country code: DE